Board of Directors

Daniela Bosshardt
Chairwoman of the Board of Directors

• Board member since 2017, born in 1972, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: After completing her studies, she practiced as a pharmacist (1996-1998). Daniela Bosshardt was a financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004). Since 2004, she has worked as an independent consultant in the healthcare sector. Daniela Bosshardt was a board member of Vifor Pharma AG (2008-2019), Verve Capital Partners AG (2017-2019) and Nobel Biocare AG (2010-2014).
•  
• Qualification: Federal Diploma in Pharmacy from the Federal Institute of Technology, Zurich (ETH).
•  
• Other main activities: Daniela Bosshardt is a member of the Board of Directors of RepRisk AG (an Environmental, Social & Governance data science company) and EGS (Ernst Göhner Stiftung) Beteiligungen AG.

Bertrand Jungo
Vice-Chairman of the Board of Directors

• Board member since 2018, born in 1965, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: From 2006 to 2017, he held the position of CEO of the Swiss department store group Manor. From 2017 until February 2020, he was CEO of Admeira AG, and from 2020 to July 2021, he served as a member of the Board of Directors at Admeira AG. He was also a member of the Advisory Board of the International Retail Summit (IRS) of the Gottlieb Duttweiler Institute (GDI) (2010 – July 2021).
•  
• Qualification: Degree as business administrator lic.rer.pol from the University of Fribourg.
•  
• Other main activities: Since August 2021, he has been a delegate of the Board of Directors of the Kulm-Group St. Moritz. Furthermore, he is a member of the Board of Neoperl AG as well as at Zoo Basel.

Pascale Bruderer

• Board member since 2020, born in 1977, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: Pascale Bruderer was a member of the National council from 2002 to 2011 (president of the National council 2009/2010) and a Member of the Council of States from 2011 to 2019. She was formerly a member of the Social Security and Health Committee. She served as president of the umbrella organisation for disabled people, Inclusion Handicap, and was the managing director of Krebsliga Aargau.
•  
• Qualification: Master’s degree in political science from the University of Zurich and education at Harvard University in Boston (USA) and at the Executive School of the University of St. Gallen.
•  
• Other main activities: Pascale Bruderer is a member of the Board of Directors of the Bernexpo Group, Tamedia and the TX Group AG. Furthermore, since 2019, she has been a co-owner and member of the executive Board of Crossiety AG.

Prof. Hon. Dr. Michel Burnier

• Board member since 2017, born in 1953, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: Prof. Hon. Dr Michel Burnier was a member of the Medicines Committee of the Swiss Association of Pharmacists until 2001 and served on the boards of Swissmedic from 2002 to 2010 and Speedel Holding AG from 2007 to 2009.
•  
• Qualification: Swiss-registered Doctor of Internal Medicine and Nephrology.
•  
• Other main activities: Prof. Hon. Dr Michel Burnier is currently Professor Emeritus at the University of Lausanne, where he was the head of the Service of Nephrology and Hypertension until July 2019 and Professor at the Medical University of Gdansk (Poland). Furthermore, he is currently on the Board of Vifor Pharma AG and is a member of the Swiss Society of Nephrology (former President), the Scientific Council of the European Society of Hypertension (former Treasurer) and the Swiss Society of Hypertension (former President). Since 2020, he has been a member of the Board of Fondation Mérine and the Editor in Chief of the journal Blood Pressure since 2022.

Judith Meier

• Board member since 2022, born in 1962, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Professional experience: From 2009 to 2016, Judith Meier headed Zurzach Care AG (formerly the Reha Clinic Group) as CEO, was a delegate from 2017 and Vice Chairwoman of the Board of Directors of Zurzach Care AG since 2019. She is a co-founder of reha at home AG (founding year 2018). From 1989 to 2001, she was a member of the Great Council of the Canton of Aargau.
•  
• Qualifications: Executive Master of Health Service Administration (Eastern Switzerland University of Applied Sciences), qualified physiotherapist.
•  
• Other activities: Judith Meier is Vice Chairwoman of the Board of Directors of Zurzach Care AG. Since 2017, she has been a member of the Board of Directors of the Cantonal Hospital of Graubünden.

Dr. Markus R. Neuhaus

• Board member since 2019, born in 1958, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: Dr Markus R. Neuhaus held various roles at PwC from 1985 on, including CEO of PwC Switzerland from 2003 to 2012, member of PwC’s Global Board from 2005 to 2007, member of the PwC Network Executive Team from 2010 to 2013, member of PwC’s Office of the Global Chairman from 2013 to 2016, and Chairman of PwC Switzerland from 2012 to 2019.
•  
• Qualification: Master of law and doctorate in law from the University of Zurich. Certified tax expert. Various management courses at international business schools (Harvard, Insead, IMD).
•  
• Other main activities: Dr Markus R. Neuhaus is Vice-Chairman of the Board of Directors of Barry Callebaut AG and Orior AG and a member of the Board of Directors of Baloise AG and Jacobs Holding AG. He also serves as Vice-Chair of the Board of Trustees of Avenir Suisse.

Dr. Andreas Walde

• Board member since 2017, born in 1962, Swiss citizen
•  
• Corporate Governance: independent member
•  
• Career highlights: After completing his studies and being admitted to the Swiss Bar, he held various legal and management positions in international chemical and pharmaceutical companies for more than 30 years with a focus on corporate governance, remuneration systems, sustainability, risk management, ethics and compliance, as well as on financial and corporate structures and M&A, e.g. at Roche (1988–1996), Clariant (1998–2010), Petroplus (2012–2013) and Vifor Pharma (since 2013). His former positions include memberships on the board of several private and (non-Swiss) public listed companies. He is a member of the board of scienceindustries and has served on the boards of SwissHoldings and the Society of Swiss Enterprises in Germany.
•  
• Qualification: Attorney-at-law and doctorate in law from the University of Basel.
•  
• Other main activities: Dr Andreas Walde is General Secretary of Vifor Pharma AG.